Biogen
BIIB
BIIB
945 hedge funds and large institutions have $25.8B invested in Biogen in 2022 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 315 increasing their positions, 386 reducing their positions, and 132 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
945
Holders Change
-57
Holders Change %
-5.69%
% of All Funds
14.95%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.19%
New
83
Increased
315
Reduced
386
Closed
132
Calls
$789M
Puts
$798M
Net Calls
-$9.27M
Net Calls Change
+$411M
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$153M |
| 2 |
Two Sigma Advisers
New York
|
$231M |
| 3 |
Man Group
London,
United Kingdom
|
$173M |
| 4 |
BlackRock
New York
|
$2.97B |
| 5 |
D.E. Shaw & Co
New York
|
$209M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
$458M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$20.2M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$4.71M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
$32.8M |
| 5 |
Amundi
Paris,
France
|
$73.5M |
